Novartis whistleblowers get big reward

Two former salesmen with Novartis will share $20.2 million. The huge sum is not a commission or bonus for their work on behalf of Novartis but for blowing the whistle on the drug company's improper practices, specifically for its marketing of the anti-epilepsy drug Trileptal for unapproved "off-label" uses. Novartis recently agreed to plead guilty and pay $422.5 million in fines and penalties,